finanzen.net
24.05.2019 01:30
Bewerten
(0)

Biopharmaceutical Bioseparation Systems Market Report 2019 - Global Annual Market Analysis, Trends, and Forecasts 2016-2024

DRUCKEN

DUBLIN, May 23, 2019 /PRNewswire/ -- The "Biopharmaceutical Bioseparation Systems - Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Biopharmaceutical Bioseparation Systems in US$ Million by the following Product Segments:

  • Chromatography Systems
  • Other Bioseparation Systems

The report profiles 55 companies including many key and niche players such as

  • 3M Company (USA)
  • 3M Purification, Inc. (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Flottweg Separation Technology (USA)
  • GEA Westfalia Separator Group GmbH (Germany)
  • GE Healthcare Life Sciences (USA)
  • KNAUER Wissenschaftliche Gerte GmbH (Germany)
  • Konik Nanobiotech SL (Spain)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Sartorius Stedim Biotech (France)
  • Repligen Corporation (USA)
  • Thermo Fisher Scientific, Inc. (USA)
  • Tosoh Bioscience, Inc. (Japan)
  • YMC Europe GmbH (Germany)

Key Topics Covered: 

1. OUTLOOK
Bioseparation Systems
Invaluable Tools in Biopharmaceutical Manufacturing
US Remains Market Leader; Developing Countries to Drive Market Growth
Chromatography Leads the Pack
Global Market for Gas Chromatography Systems
Competitive Landscape 


2. INDUSTRY OVERVIEW
A Peek into Biopharmaceutical Manufacturing
Downstream Processing of Biosynthetic Products
An Overview
Growing Biopharmaceutical Market Drives Demand for Bioseparation Systems
New Biologic License Application (BLA) Approvals-2017
New Biologic License Application (BLA) Approvals: 2016
New Biologic License Application (BLA) Approval: 2015
Biopharmaceutical Industry Transforms Downstream Processing
Growing Biological Drug Manufacturing Capacity to Drive Growth
Growing Market for Monoclonal Antibodies
A Key Review of Current Status and Future Prospects
Approved Monoclonal Antibodies: 2014-2017
An Insight into Bioseparation of mAbs
Growing Biosimilars Market
A Clear Advantage for Bioseparation Technologies
Patent Expiries of Major Biopharmaceutical Drugs in the US and Europe
US APPROVED BIOSIMILARS AS OF DECEMBER 2017
EUROPE APPROVED BIOSIMILARS AS OF DECEMBER 2017
R&D Funding Crucial for Biologics and Bioseparation Market
Huge Biopharmaceutical Pipeline
A Clear Indicator of Future Prospects

3. BIOSEPARATION TECHNOLOGIES KEY MARKET TRENDS
Increasing Need for Further Advances in Downstream Processing Techniques
Process Optimization and Cost Reduction
Key Goals of Innovations in Bioseparation
Continuous Bioseparation Gains Momentum
Process Intensification
Single-Use Systems Play a Key Role
Minimizing Centrifugation Steps
Integration of Down-Stream and Up-Stream
Developmental Efforts
Focus on Enhancing Capture Increases
Introduction of Diversified Resins on the Rise
Multicolumn System Lower Buffer and Resin Requirement
Single-Use Disposable Technologies Gain Attention
Select Commercial Disposable/Single-Use Technologies by Process Technique
Innovations in Single-use Systems
Increasing Biopharma Productivity and Efficiency via Continuous Manufacturing
Changing Paradigm of Primary Recovery in Bioseparation
Growing Use of Membrane Filtration in Biopharmaceutical Manufacturing
Chromatography
The Gold Standard Purification Technology
Continuous Chromatography- A Key Technology for the Biopharma Sector
Challenges to Separate Active Pharmaceutical Ingredients, Chromatography to the Rescue
Inherent Benefits of Membrane Chromatography to Drive its Use in Bioprocessing
SMBC
An Old Approach Gaining Significant Attention
Superior Efficiency Drives Use of Synthetic Ligands in Affinity Chromatography
A Comparison of Protein and Synthetic Ligands
Increasing Alternatives to Protein A Column based Capturing
Twin-Column SMB
An Emerging Alternative to Protein A Columns
Chiral Chromatography Increases in Popularity
Flexible and Selective Chromatography Improves Biopharmaceutical Efficiencies
Chromatography Efficiency and Selectivity
Mixed-Mode Chromatography
Multimode Chromatography
Mixed-Mode and Multimode Media Offer Cost Savings
Awareness of Mixed Mode and Multimode Media Operating Modes Critical
Magnetic Separation as an Alternative to Chromatography
A Review
Reversible Precipitation
A Novel Bioseparation Technology

4. PRODUCT OVERVIEW
Biological Products
An Overview
Classification of Biological Products by Application
Classification of Biological Products by Chemical Nature
Bioseparation
An Overview
Commonly Used Bioseparation Processes by Factors
Bioseparation
A Challenging, Complex, and Expensive Process
Stages of Biomolecule Recovery and Relevant Bioseparation Techniques Used
Classification of Bioseparation Techniques based on Resolution and Throughput
Bioseparation Costs as a Percentage of Processing by Biological Product
Key Bioseparation Techniques
Chromatography
Centrifugation
Membrane Separation
Filtration
Overview of Other Bioseparation Techniques
Adsorption
Extraction
Precipitation
Classification of Bioseparation Techniques based on Physical Form
Particle-Liquid Separation
Particle-Particle Separation
Solute-Solvent Separation
Solute-Solute Separation
Liquid-Liquid Separation
Particle-Solute Separation
RIPP in Bioseparation
The Conventional Scheme for Developing Processes

5. PRODUCT INTRODUCTIONS/APPROVALS
GE Healthcare Introduces MabSelect PrismA
Pall Introduces Flexible Single-use Chromatography System
MilliporeSigma Launches Eshmuno Affinity Chromatography Resins
PerkinElmer Introduces Clarus 590 and 690 GC Instruments
Sartorius Stedim Biotech Releases Sartobind Cassettes
Ellutia Chromatography Solutions Unveils 500 Series Range of Instruments
Kaneka Corporation Launches KANEKA KanCapA 3G
Pall Life Sciences Introduces Cadence BioSMB Process System
Thermo Fisher Exhibits SMART Digest Kit
Merck Launches Wide Range of Products for Separation and Analysis
Agilent Technologies Introduces New Line of AdvanceBio SEC Columns

6. RECENT INDUSTRY ACTIVITY
Waters Corp. Launches ACQUITY Arc Bio System
GE Healthcare Acquires Puridify
MilliporeSigma Inks MoU with Samsung BioLogics
Merck Acquires Natrix Separations
Repligen Merges with Spectrum Labs
Waters Enters into a Co-Marketing Agreement with Wyatt Technology
JLS Expands Amsphere A3 Production Capacity
YMC Buys Land in the Annex Kyoto Miwa Industrial Park
KNAUER and 3B Pharmaceuticals Delivers Purification Process for Camelid Antibodies
ATG Enters into a Service Agreement with LEWA-Nikkiso America
Repligen Buys Atoll
Pall Enters into a Supply Agreement with KANEKA
Merck Acquires Sigma-Aldrich
EMD Millipore Launches Sterilizing-Grade Millipore Express PHF Hydrophilic Filters
Anteo Diagnostics Inks South Korean Distribution Agreement with KomaBiotech
GE Healthcare and Sartorius Stedim Biotech Ink OEM Supply Agreement for Sartobind Technology
EMD Millipore Unveils Pellicon Tangential Flow Filtration System
ImmunoReagents and ProteoVec Launch PV-Pure Ig Antibody Purification Kits
Pall Acquires Tarpon's BioSMB Platform

7. FOCUS ON SELECT PLAYERS

8. GLOBAL MARKET PERSPECTIVE

Total Companies Profiled:

  • 55 (including Divisions/Subsidiaries 67)
  • The United States (33)
  • Canada (2)
  • Japan (6)
  • Europe (21)
    • France (3)
    • Germany (10)
    • The United Kingdom (3)
    • Spain (1)
    • Rest of Europe (4)
  • Asia-Pacific (Excluding Japan) (5)

For more information about this report visit https://www.researchandmarkets.com/r/gfyn3n

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/biopharmaceutical-bioseparation-systems-market-report-2019---global-annual-market-analysis-trends-and-forecasts-2016-2024-300856140.html

SOURCE Research and Markets

Technische Marktanalyse

Wie geht's an der Börse weiter? Setzt sich der Zick-Zack-Kurs fort oder geht es demnächst kräftig nach unten? Am Montag ab 18 Uhr analysiert Achim Matzke die Situation bei Dax, Dow und Co. Jetzt kostenlos anmelden!
Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht tiefer ins Wochenende -- Wall Street schließt schwächer -- Bechtle dämpft Erwartungen an Umsatzwachstum -- Broadcom, Varta, Autowerte, Rheinmetall im Fokus

CropEnergies etwas zuversichtlicher für Geschäftsjahr. Fiat Chrysler koopiert mit Engie und Enel bei Ladestationen. 1&1 Drillisch-Aktie und United Internet-Aktie von Unsicherheit geplagt. Swiss Re bringt Tochter ReAssure im Juli an Londoner Börse. Huawei: Android-Ersatz könnte "binnen Monaten" kommen. Bayer bleibt bei Glyphosat - Aber Milliarden für Alternativen.

Die 5 beliebtesten Top-Rankings

Das hat sich geändert
Diese Aktien hat George Soros im Depot
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
Das verdienen Aufsichtsratschefs in DAX-Konzernen
Deutlich unter Vorstandsgehältern
Die Länder mit den größten Goldreserven 2019
Wer lagert das meiste Gold?
Die zehn größten Kapitalvernichter
Hier wurde am meisten Anlegergeld verbrannt
mehr Top Rankings

Umfrage

Sind Sie an einem Investment in die Cannabis-Branche interessiert?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Microsoft Corp.870747
Scout24 AGA12DM8
Daimler AG710000
Apple Inc.865985
Amazon906866
Wirecard AG747206
NEL ASAA0B733
TeslaA1CX3T
Beyond MeatA2N7XQ
Allianz840400
BMW AG519000
BASFBASF11
Infineon AG623100
E.ON SEENAG99